Physician profile
Brittany Thomas
NPI 1194969733
$841.31
in general payments reported to CMS, 2019-2025
16 companies · $75.53 in 2025
The $75.53 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $403 · 2020: $191 · 2021: $19.69 · 2023: $19.62 · 2024: $132 · 2025: $75.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $157 · Education: $70.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $156.72 |
| Education | $70.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $150.61 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.85 | 2019 | |
| Fresenius USA Marketing, INC. | $93.74 | 2020 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $86.20 | 2019 | |
| Vifor Pharma, INC. | $65.57 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $63.22 | 2025 | Belbuca |
| Travere Therapeutics, INC. | $50.99 | 2024 | |
| Opko Pharmaceuticals, LLC | $44.34 | 2019-2020 | |
| Edwards Lifesciences Corporation | $37.52 | 2024 | Hemosphere |
| Amgen INC. | $25.83 | 2019 | |
| Daiichi Sankyo INC. | $25.54 | 2024 | Enhertu |
| Aurinia Pharma U.S., INC. | $19.69 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.62 | 2023 | |
| Genzyme Corporation | $19.15 | 2019 | |
| Lemaitre Vascular, INC. | $18.13 | 2024 | Artegraft Vascular Graft |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Molnlycke Health Care US, LLC | $12.31 | 2025 | Mlnlyckez-Flo Fluidized Positioner |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.